BRD2 and polycystic ovary syndrome: This result helps in understanding why ovarian stimulation in women committed to assisted reproductive technologies (ART) is highly facilitated by myo-Ins treatment, which can increase the sensitivity of polycystic ovaries to gonadotropins, leading to a reduction in the doses of FSH required to induce ovulation [48].